CML, Chronic Phase

Explore clinical trials studying CML, Chronic Phase. Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

CML, Chronic Phase trial results

Recruiting

PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML

NCT06409936

Conditions: Bone Marrow Diseases, CML, Chronic Phase, Chronic Disease, +15 more
Locations: Hospital del Mar (Barcelona) Barcelona, Spain

Hospital Universitario Basurto Bilbao, Spain

Institut Català d'Oncologia Girona Girona, Spain

Hospital Virgen de las Nieves Granada, Spain

View Trial Details

Recruiting

Study of Olverembatinib (HQP1351) in Patients With CP-CML

NCT06423911

Conditions: Bone Marrow Diseases, CML, CML, Chronic Phase, +14 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs

NCT03459534

Conditions: Bone Marrow Diseases, CML - Philadelphia Chromosome, CML, Chronic Phase, +15 more
Locations: Territorial State Budgetary Institution Barnaul, Russia

Federal State Budgetary Institution of Science Kirov, Russia

Federal State Budgetary Institution Moscow, Russia

Hematology Centre based on City Clin. Hosp. n.a. S.P. Botkin Moscow, Russia

View all 18 locations

View Trial Details

Recruiting

A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.

NCT05367700

Conditions: Bone Marrow Diseases, CML, Accelerated Phase, CML, Chronic Phase, +14 more
Locations: Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

NCT05367765

Conditions: Bone Marrow Diseases, CML, Chronic Phase, Chronic Disease, +12 more
Locations: Institute of Hematology and Oncology, Harbin The First Hospital Harbin, Heilongjiang, China

View Trial Details

Completed

Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients

NCT03885830

Conditions: Bone Marrow Diseases, CML (Chronic Myelogenous Leukemia, CML - Philadelphia Chromosome, +16 more
Locations: UNC Hospital Chapel Hill, North Carolina, United States

View Trial Details

Completed

Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

NCT04883125

Conditions: Bone Marrow Diseases, CML, Chronic Phase, Chronic Disease, +13 more
Locations: Faculty of Medicine Al Mansurah, Dakahlia Governorate, Egypt

View Trial Details

CML, Chronic Phase

CML, Chronic Phase trial results

PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML

Study of Olverembatinib (HQP1351) in Patients With CP-CML

A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs

A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.

A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients

Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

Related conditions